Sign in

CIK 0000318154 · Large accelerated filer

Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
953540776
Phone
(805)447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-02 ISHRAK OMAR Director Grant or award +140.74 1,075.74
2022-05-02 Kullman Ellen Jamison Director Grant or award +140.74 8,752.82
2022-04-27 Santos Esteban EVP, Operations Shares withheld for taxes −599 $249.87 $150K 55,321
2022-04-27 REESE DAVID M EVP, Research and Development Shares withheld for taxes −184 $249.87 $46K 47,755
2022-04-27 Miller Derek SVP, Human Resources Shares withheld for taxes −273 $249.87 $68K 5,243
2022-04-27 Louie Linda H. VP, Finance & CAO Shares withheld for taxes −17 $249.87 $4K 9,004
2022-04-27 Khosla Rachna SVP, Business Development Shares withheld for taxes −28 $249.87 $7K 6,828
2022-04-27 Grygiel Nancy A. SVP & CCO Shares withheld for taxes −60 $249.87 $15K 14,329
2022-04-27 Graham Jonathan P EVP, Gen. Counsel & Secy. Shares withheld for taxes −599 $249.87 $150K 48,596
2022-04-27 Bradway Robert A Chairman, CEO and President Shares withheld for taxes −2,547 $249.87 $636K 610,769
2022-03-18 Santos Esteban EVP, Operations Shares withheld for taxes −4,370 $235.86 $1.0M 55,920
2022-03-18 REESE DAVID M EVP, Research and Development Shares withheld for taxes −4,995 $235.86 $1.2M 47,939

Page 28 of 28 · 552 trades